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pore than a decade has passed since we first commented on
oth the promise and potential pitfalls of “cardiovascular
corecard medicine” (1,2). In this issue of the Journal,
esnic and Welt (3) report on their real-world experiences
ith public outcomes reporting for percutaneous coronary
ntervention (PCI) at Brigham and Women’s Hospital in
assachusetts. Their findings raise a number of fascinating
ssues that deserve careful consideration by cardiologists,
dministrators, researchers, policy makers, payers, and pa-
ients. Although some might see their work as an attempt to
ationalize a mediocre performance rating, we believe their
eport serves a nobler purpose—it is the proverbial canary in
he coal mine, warning of serious challenges inherent in
elying upon in-hospital mortality as a meaningful measure
f quality of care.
Public reporting of mortality outcomes in medicine has a
ong and complicated history, beginning, perhaps, with the
ll-fated Dr. Earnest Codman. Dr. Codman, also from a
restigious Boston institution, daringly proposed to report
is hospital’s mortality results, believing that this would
ttract informed consumers and would soon become stan-
ard practice for the country (4). Unfortunately for Dr.
odman, his hospital shortly went out of business and
obody followed his example.
Eighty years after the inglorious end of Dr. Codman’s
xperiment, believing that outcomes reporting would soon
ain widespread acceptance, we predicted that:
The convergence of concern about costs of medical care, the avail-
ability of large amounts of clinical outcome data in computerized
databases, and dramatic advances in the methods of assessing factors
related to outcome have ushered in a new era of accountability for
physicians, hospital and health care systems (1).
Although our proposal (like Dr. Codman’s) was a bit
remature, a decade later, public reporting of hospital
ortality data is now a reality for all U.S. cardiologists. In
ddition to the statewide activities discussed in this article,
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outinely reports 30-day hospital mortality rates for acute
yocardial infarction and heart failure, and will soon add
CI mortality and heart failure readmission rates (5).
As we enter this new era of accountability, it is essential
hat the health services research community investigate both
he intended and unintended consequences of these policies.
esnic and Welt (3) contribute to this evaluation by
crutinizing the public reporting process for PCI mortality
n Massachusetts. Using their own hospital as an example,
he investigators describe the challenges in benchmarking
erformance for acute PCI outcomes. They point out that
resent-day PCI mortality rates reflect relatively rare events
hat occur most commonly among patients who arrive at the
atheterization laboratory with a multifactorial profile of
xtreme illness (e.g., in cardiogenic shock, with acute
yocardial infarction, or with other major comorbid con-
itions). They also note that current risk-adjustment models
ften fail to fully capture these complexities, and they
rovide convincing evidence that public profiling efforts may
ave the unintended result of encouraging clinicians to
void those high-risk patients most likely to receive the
reatest benefit from the procedure.
Is the public release of PCI mortality data good or bad for
ur field? We might conclude that it is both, depending in
art on the goal of such reporting. An oft-stated reason for
ublic reporting programs is to inform consumers’ choices,
o that they can select a quality provider and hospital for
heir PCI procedure. This rationale, however, falls flat for
everal reasons. First, mortality is a crude measure to apply
o situations characterized by very low event rates, or for
hich the ability to predict the outcome depends upon
actors that are poorly collected by current systems. As
esnic and Welt (3) note, PCI mortality occurred most
ften when it was performed under urgent or emergent
onditions (and therefore, in circumstances in which con-
umer choice is moot). Under elective conditions, mortal
omplications related to PCI are exceedingly rare, making it
nlikely that provider quality can be differentiated from
hance background events. For example, an earlier study
oncluded that under plausible conditions, up to 90% of true
oor PCI performers could be missed by a profiling system,
nd 60% to 70% of physicians identified as poor quality
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Public Reporting of Quality Measures March 10, 2009:831–3roviders might be falsely labeled, simply because of purely
andom variation (6). Additionally, public mortality data are
or more years out of date when reported. Because
stimates for hospitals also tend to vary markedly by year,
ast outcomes information, like stock market warnings, may
ot reflect current or future performance.
On a more positive note, provider profiling efforts can in fact
einforce clinicians’ and administrators’ interest in the quality
mprovement (QI) process. Again, Resnic and Welt’s paper (3)
llustrates this effect. It is debatable whether Brigham and
omen’s Hospital would have assigned 3 full-time employees
o support PCI clinical data collection and QI efforts had it not
een for state mandates or the impending public release of
erformance data. Additionally, although the detailed review
fforded to each PCI mortality event is laudable, such intensive
I was in part motivated by the desire to demonstrate flaws in
he provider profiling system rather than purely to identify
pportunities for preventing errors. Thus, although the public
elease of outcomes data may not necessarily serve the purpose
f informing the public, it can nonetheless supply the strong
xternal motivation needed to pursue internal QI activities.
Given that public reporting of death rates is likely here to
tay, what can we do to make the best use of this informa-
ion? Resnic and Welt (3) make several good suggestions,
hich we would like to highlight and augment: First, we are
keptical that any amount of tuning can resolve the difficult
ssue of predicting death after PCI with sufficient accuracy,
r can overcome statistical challenges arising from the laws
f small numbers. Although we do not support the public
elease of potentially misleading PCI mortality information,
e do support state and national efforts that would mandate
ospitals to collect and compare clinical information on
CI, such as that required in Massachusetts and offered
oluntarily by the American College of Cardiology (ACC)–
ational Cardiovascular Data Registry (7). Armed with
uch data, we would further encourage all institutions to
outinely review any deaths occurring during PCI in a
anner similar to that outlined by Resnic and Welt (3),
ith the main goal of identifying opportunities for future
are improvement.
In place of the public release of procedure-related out-
omes, we would argue for better and more complete
nalysis of condition-specific outcomes (i.e., acute myocar-
ial infarction and heart failure). For example, by examining
ll patients with MI, one can lessen concerns of provider
case selection creep,” as both patients with and without a
rocedure will ultimately be included in the denominator.
et in order to pursue such a course, we will need improved,
omprehensive data, since current provider profiling efforts
ely on administrative databases that are notoriously limited
n terms of the completeness and accuracy needed for risk
djustment (8). Instead of implementing flawed profiling
ith inadequate administrative data, we again would sug-
est expanding participation in national clinical registries,
uch as those run by the ACC and the American Heart
ssociation. In addition to providing incentives or man-ates for participation, they could also provide support for
uditing registries for completeness and accuracy and, ide-
lly, for including longitudinal outcomes information.
We would also argue that any outcomes reporting system
hould be augmented with data on care process and appro-
riateness. Assuring that PCI patients receive optimal
edical therapy may be as important as the procedure itself
or long-term health outcomes, as demonstrated by recent
rials (9). Thus, reporting on the routine use of these
vidence-based secondary prevention therapies may increase
heir ubiquity, which might potentially save many more lives
han reporting on small differences in the quality of the
rocedure itself could.
Similarly, as Resnic and Welt (3) acutely point out,
election of patients likely to benefit from the procedure is
ritical. Close monitoring of procedural appropriateness can
elp us avoid unnecessary risk to patients lacking good
ndications for a given procedure, while simultaneously
educing the associated financial costs. Procedural appropri-
teness criteria for PCI are being developed by the ACC to
acilitate such measurement, and digital technology now
ermits remote oversight of angiograms to confirm ana-
omic findings and allow peer feedback. But again, external
ncentives must be in place before institutions will be willing
o routinely collect and report these data.
Better education of the public and of provider commu-
ities on how to interpret and make use of this information
s essential. We also need better methods for summarizing
omplex, multidimensional information on care structure,
rocesses, and outcomes into composite measures that are
eaningful and reflect their intended purpose and values (10).
Finally, professional regulations are needed to prevent
nappropriate marketing of comparisons of quality data that
re linked with advertisements promoting false or overstated
mpressions. Even in an era of public transparency and
ompetition, the main role of quality assessment should be
o promote QI, not increase market share.
In summary, Resnic and Welt (3) have done all of us in
he cardiology community a favor by “singing” about the
roblems with the application of PCI mortality risk scores
o assess comparative quality. As with any quality tool, the
alue of the measurement will be determined by the wisdom
f those who use it.
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